These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27929669)

  • 1. FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.
    Ma Y; Kirby BJ; Fairbridge NA; Karaplis AC; Lanske B; Kovacs CS
    Endocrinology; 2017 Feb; 158(2):252-263. PubMed ID: 27929669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
    Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
    Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
    J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
    Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.
    Sneddon WB; Ruiz GW; Gallo LI; Xiao K; Zhang Q; Rbaibi Y; Weisz OA; Apodaca GL; Friedman PA
    J Biol Chem; 2016 Sep; 291(36):18632-42. PubMed ID: 27432882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
    Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
    J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.
    Martins JS; Liu ES; Sneddon WB; Friedman PA; Demay MB
    Endocrinology; 2019 Oct; 160(10):2204-2214. PubMed ID: 31237611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic causes of hypophosphatemia.
    Puente N; Solis P; Riancho JA
    Minerva Med; 2024 Jun; 115(3):320-336. PubMed ID: 38727708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis.
    Christov M; Koren S; Yuan Q; Baron R; Lanske B
    Endocrinology; 2011 May; 152(5):2031-6. PubMed ID: 21427221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.
    Brownstein CA; Zhang J; Stillman A; Ellis B; Troiano N; Adams DJ; Gundberg CM; Lifton RP; Carpenter TO
    Endocrinology; 2010 Feb; 151(2):492-501. PubMed ID: 19952276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of 24-hydroxylated catabolism increases calcitriol and fibroblast growth factor 23 and alters calcium and phosphate metabolism in fetal mice.
    Bennin D; Hartery SA; Kirby BJ; Maekawa AS; St-Arnaud R; Kovacs CS
    JBMR Plus; 2024 May; 8(5):ziae012. PubMed ID: 38577520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and sex effects on FGF23-mediated response to mild phosphate challenge.
    Tippen SP; Noonan ML; Ni P; Metzger CE; Swallow EA; Sacks SA; Chen NX; Thompson WR; Prideaux M; Atkins GJ; Moe SM; Allen MR; White KE
    Bone; 2021 May; 146():115885. PubMed ID: 33618073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus: Chronicles of the epistemology of a vital element.
    Eknoyan G; Lederer ED
    Clin Nephrol; 2024 Jun; ():. PubMed ID: 38836367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.
    Pedersen L; Christensen LL; Pedersen SM; Andersen M
    J Endocrinol Invest; 2017 May; 40(5):529-538. PubMed ID: 28000180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor-23-A Potential Uremic Toxin.
    Kuczera P; Adamczak M; Wiecek A
    Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27941640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Oxidative Stress Related Genes in a Chronic Kidney Disease Attributed to Specific Geographical Locations of Sri Lanka.
    Sayanthooran S; Magana-Arachchi DN; Gunerathne L; Abeysekera TD; Sooriyapathirana SS
    Biomed Res Int; 2016; 2016():7546265. PubMed ID: 27975059
    [No Abstract]   [Full Text] [Related]  

  • 18. Klotho as a Therapeutic Target during the Development of Renal Fibrosis.
    Doi S; Masaki T
    Contrib Nephrol; 2017; 189():178-183. PubMed ID: 27951565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
    Kosk D; Kramer H; Luke A; Camacho P; Bovet P; Rhule JP; Forrester T; Wolf M; Sempos C; Melamed ML; Dugas LR; Cooper R; Durazo-Arvizu R
    J Bone Miner Metab; 2017 Nov; 35(6):666-674. PubMed ID: 27942978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.